eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2015
vol. 19
 
Share:
Share:
more
 
 
abstract:
Original paper

Analysis of the influence of parenteral cancer chemotherapy on the health condition of oral mucosa

Mansur Rahnama, Barbara Madej-Czerwonka, Izabela Jastrzębska-Jamrogiewicz, Rafał Jamrogiewicz

Contemp Oncol (Pozn) 2015; 19 (1):77–82
Online publish date: 2015/03/26
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Aim of the study: The present study was aimed at estimating the prevalence of oral complications in cancer patients receiving chemotherapy.

Material and methods: The study was conducted on a group of 58 patients treated with chemotherapy (study group). The control group consisted of 30 healthy patients. Dental status and oral mucosa were examined using the criteria of the National Cancer Institute Toxicity Criteria Scale. The levels of stimulated and unstimulated saliva flow were analysed.

Results: In the group of patients treated with chemotherapy, 59% of patients had inflammatory changes of the soft tissues of the mouth, such as erythema, erosions, or ulcers, which were discovered during dental examination. Such changes occurred in only 10% of patients in the control group. Six of the patients treated with chemotherapy reported pain with intensity was so severe that it caused swallowing difficulties. Patients in the study group frequently complained about the presence of dry mouth, taste disturbances, nausea, and vomiting. These symptoms occurred in 70% of patients undergoing oncological treatment. In both stimulated and unstimulated saliva secretion, the rates were significantly lower in patients from the research group, when compared to the control group.
keywords:

chemotherapy, oral mucositis, treatment complications, cytotoxicity

references:

Galili D, Donitza A, Garfunkel A, Sela MN. Gram-negative enteric bacteria in the oral cavity of leukemia patients. Oral Surg Oral Med Oral Pathol 1992; 74: 459-62.

Solomayer EF, Feuerer M, Bai L, et al. Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer. Clin Cancer Res 2003; 9: 174-80.

de Almeida Pdel V, Grégio AM, Machado MA, de Lima AA, Azevedo LR. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 2008; 9: 72-80.

Doorenbos AZ, Berger AM, Brohard-Holbert C, et al. 2008 ONS research priorities survey. Oncol Nurs Forum 2008; 35: 100-7.

Sonis ST. A biological approach to mucositis. J Support Oncol 2004; 2: 21-36.

lting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 2003; 98: 1531-9.

Mazzeo MA, Linares JA, López MM, et al. Analysis of saliva samples from oncological patients treated with 5-fluorouracil and leucovorin calcium by scanning electron microscopy with energy dispersive system. J Oral Pathol Med 2013; 42: 788-92. doi: 10.1111/jop.12078.

Dikken C, Sitzia J. Patients’ experiences of chemotherapy: side-effects associated with 5-fluorouracil + folinic acid in the treatment of colorectal cancer. J Clin Nurs 1998; 7: 371-9.

Brown CG, McGuire DB, Peterson DE, Beck SL, Dudley WN, Mooney KH. The experience of a sore mouth and associated symptoms in patients with cancer receiving outpatient chemotherapy. Cancer Nurs 2009; 32: 259-70.

Cheng KK. Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy. J Clin Nurs 2007; 16: 2114-21.

Deslauriers N, Coulombe C, Carré B, Goulet JP. Topical application of a corticosteroid destabilizes the host parasite relationship in a experimental model of the oral carrier state of Candida albicans. FEMS Immunol Med Microbiol 1995; 11: 45-6.

Silverman RJ, Nobbs AH, Vickerman MM, Barbour ME, Jenkinson HF. Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities. Infect Immun 2010; 78: 4644-52.

Shirtliff ME, Peters BM, Jabra-Rizk MA. Cross-kingdom interactions: Candida albicans and bacteria. FEMS Microbiol Lett 2009; 299: 1-8.

Harrison T, Bigler L, Tucci M, Pratt L, Malamud F, Thigpen JT, Streckfus C, Younger H. Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study. Spec Care Dentist 1998; 18: 109-12.

Jensen SB, Mouridsen HT, Reibel J, Brünner N, Nauntofte B. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction. Oral Oncol 2008; 44: 162-73.

McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 1998; 34: 484-90.

Rahnama M, Jastrzębska I, Jamrogiewicz R, Kocki J. IL-1 and IL-1levels in blood serum and saliva of menopausal women. Endocr Res 2013; 38: 69-76.

Agha-Hosseini F, Mirzaii-Dizgah I, Moghaddam PP, Akrad ZT. Stimulated whole salivary flow rate and composition in menopausal women with oral dryness feeling. Oral Dis 2007; 13: 320-3.

Pels E. Oral mucositis in children suffering from acute lymphoblastic leukaemia. Contemp Oncol (Pozn) 2012; 16: 12-5.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe